Bee Vectoring Technologies Closes Debt Settlement
Bee Vectoring Technologies Closes Debt Settlement
Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - November 24, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") announces that it has closed the debt settlement agreement (the "Settlement Agreement") previously announced on November 17, 2023. Pursuant to the Settlement Agreement, the Company issued an aggregate of 2,765,138 Common shares at a deemed price of $0.06 per Common share to the creditor in full satisfaction of an outstanding cash payment due in the amount of $165,908.34 for legal fees.
安大略省密西沙加和加利福尼亞州薩克拉門託--(Newsfile Corp.-2023 年 11 月 24 日)- Bee Vectoring Technologies International Inc.(CSE:BEE)(CSE:BEE)(CSE:BEE)(“公司” 或 “BVT”) 宣佈已結束先前於2023年11月17日宣佈的債務和解協議(“和解協議”)。根據和解協議,公司以每股普通股0.06美元的認定價格向債權人發行了總計2765,138股普通股,以充分償還未支付的165,908.34美元的律師費現金。
The securities issued pursuant to the Settlement Agreement have a statutory hold period accordance with applicable securities laws which will expire on March 25, 2024.
根據和解協議發行的證券具有符合適用的證券法的法定持有期,該期限將於2024年3月25日到期。
About Bee Vectoring Technologies International Inc.
關於 蜜蜂矢量技術國際公司。
BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240 billion crop protection and fertilizer market. BVT has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. BVT's award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally-derived pesticides (called biologicals) to be delivered directly to blooms, providing improved crop protection and yield results than traditional chemical pesticides - and improving the health of the soil, the microbiome and the environment. Currently, BVT has 55 granted patents, over 35 patents pending in all major agricultural countries worldwide and has US EPA registration of its Vectorite with CR-7 (EPA Registration No. 90641-2) for sale as a registered biological fungicide for use on the labeled crops.
農業科技公司BVT是一家市場顛覆者,在2400億美元的作物保護和化肥市場中擁有巨大的全球市場機會。BVT開創了一種天然的精準農業系統,該系統通過使用商業種植的蜜蜂爲農作物提供生物農藥替代品,取代了化學殺蟲劑和浪費性的植物保護產品噴霧應用。BVT屢獲殊榮的精確矢量技術對蜜蜂完全無害,它允許將微量的天然衍生殺蟲劑(稱爲生物製劑)直接輸送到花朵中,與傳統的化學殺蟲劑相比,它提供了更好的作物保護和產量結果,並改善了土壤、微生物組和環境的健康。目前,BVT擁有55項已獲授權的專利,全球所有主要農業國家有超過35項專利正在申請中,其Vectorite已在美國環保局註冊爲CR-7(EPA註冊號90641-2),作爲註冊的生物殺菌劑出售,用於貼有標籤的農作物。
Additional information can be viewed at the Company's website . To receive regular news updates from the Company, subscribe at .
其他信息可以在公司的網站上查看。要接收公司的定期新聞更新,請訂閱。
BVT Company Contact:
Ashish Malik, President & CEO, BVT
info@beevt.com
BVT 公司聯繫方式:
BVT 總裁兼首席執行官 Ashish Malik
info@beevt.com
BVT Investor Contact:
Babak Pedram
Virtus Advisory Group
Tel: 416-995-8651
bpedram@virtusadvisory.com
BVT 投資者聯繫方式:
Babak Pedram
Virtus 諮詢小組
電話:416-995-8651
bpedram@virtusadvisory.com
The CSE has neither approved nor disapproved the contents of this press release. The CSE does not accept responsibility for the adequacy or accuracy of this release. Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to the Company, "annual revenue potential", are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions, including: planted acres, selling price of competitive chemical pesticides and the US to Canadian dollar exchange rate. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include changes in law, competition, litigation, the ability to implement business strategies and pursue business opportunities, state of the capital markets, the availability of funds and resources to pursue operations, new technologies, the ability to protect intellectual property rights, the ability to obtain patent protection for products, third-party intellectual property infringement claims, regulatory changes affecting products, failing research and development activities, the ability to reach and sustain profitability, dependence on business and technical experts, the ability to effectively manage business operations and growth, issuance of debt, dilution of existing securities, volatility of publicly traded securities, potential conflicts of interest, unlikelihood of dividend payments, the potential costs stemming from defending third-party intellectual property infringement claims, the ability to secure relationships with manufacturers and purchasers, as well as general economic, market and business conditions, as well as those risk factors discussed or referred to in the Company's Filing Statement dated August 14,2020, filed with the CSE and securities regulatory authorities in certain provinces of Canada and available at . Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. All figures are in Canadian dollars.
CSE既未批准也未批准本新聞稿的內容。CSE對本新聞稿的充分性或準確性不承擔任何責任。本新聞稿中包含的某些陳述構成 “前瞻性信息”,該術語已在適用的加拿大證券立法中定義。“可能”、“會”、“可以”、“應該”、“潛力”、“將”、“尋求”、“打算”、“計劃”、“預期”、“相信”、“估計”、“預期” 以及與公司相關的類似表述 “年收入潛力”,旨在識別前瞻性信息。除歷史事實陳述以外的所有陳述都可能是前瞻性信息。此類聲明反映了公司當前對未來事件的看法和意圖,以及公司掌握的最新信息,並受某些風險、不確定性和假設的影響,包括:種植面積、有競爭力的化學農藥的銷售價格以及美元兌加元的匯率。在提供前瞻性信息時應用了重大因素或假設。如果其中一個或多個風險或不確定性出現,則許多因素可能導致此類前瞻性信息可能表達或暗示的實際結果、業績或成就與此處描述的有所不同。這些因素包括法律的變化、競爭、訴訟、實施商業戰略和尋求商機的能力、資本市場狀況、開展業務所需的資金和資源的可用性、新技術、保護知識產權的能力、獲得產品專利保護的能力、第三方知識產權侵權索賠、影響產品的監管變化、研發活動失敗、實現和維持盈利的能力、對業務的依賴和技術專家、有效管理業務運營和增長的能力、發行債務、稀釋現有證券、公開交易證券的波動性、潛在的利益衝突、不太可能支付股息、爲第三方知識產權侵權索賠進行辯護所產生的潛在成本、與製造商和購買者的關係以及總體經濟、市場和商業狀況以及公司備案聲明中討論或提及的風險因素日期爲2020年8月14日,已向加拿大某些省份的CSE和證券監管機構提交,可在以下網址查閱。如果任何因素以意想不到的方式影響公司,或者如果前瞻性信息所依據的假設被證明不正確,則實際業績或事件可能與預測的結果或事件存在重大差異。本警示聲明明確對任何此類前瞻性信息進行了全面限定。此外,公司對此類前瞻性信息的準確性或完整性不承擔任何責任。本新聞稿中包含的前瞻性信息自本新聞稿發佈之日起編制,除非適用法律要求,否則公司沒有義務公開更新或修改任何前瞻性信息。所有數字均以加元爲單位。
To view the source version of this press release, please visit
要查看本新聞稿的源版本,請訪問
譯文內容由第三人軟體翻譯。